Xilio Therapeutics Statistics
NASDAQ: XLOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.56-0.085 (-1.11%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Xilio Therapeutics by the numbers
Xilio Therapeutics has a market capitalization of $53.4 million based on 7.06M shares outstanding. Its trailing P/E ratio is 11.6. The stock trades 11.6% below its 50-day average and 10.8% below its 200-day average.
Average daily trading volume is 11.54K shares, or about $87,265 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XLO valuation vs. peer median
| Metric | XLO | Peer median | Difference |
|---|---|---|---|
| Market cap | $53.40M | $53.00M | +1% |
| Avg. volume | 11.54K | 114.54K | -90% |
Peer median across 8 companies: CTOR, XBIT, LFVN, BOLD, AZR, ALDX, CLNN, KZIA.
Valuation
- Market cap
- $53.40M
- P/E (TTM)
- 11.63
- Price / sales (latest FY)
- 1.22
- EPS (TTM)
- $0.65
- Shares outstanding
- 7.06M
Price and trading
- Previous close
- 7.65
- Open
- 7.60
- Day range
- 7.07 – 7.60
- 52-week range
- 6.47 – 10.71
- 52-week change
- -28.29%
- Beta
- —
- Volume
- 20.10K
- Average volume
- 11.54K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2025
Additional statistics
- Market Cap
- 53.40M
- Pe
- 11.63
- Forward Pe
- -13.03
- Eps
- 0.65
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.71
- Week52 Low
- 6.47
- Avg Volume
- 11,543.00
- Shares Outstanding
- 7.06M
- Ma50
- 8.56
- Ma200
- 8.48
- Earnings Date
- Aug 6, 2025
- Pct From52w High
- -29.41%
- Pct From52w Low
- 16.88%